These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12372500)

  • 1. Synthesis and evaluation of potent pyrrolidine H(3) antagonists.
    Vasudevan A; Conner SE; Gentles RG; Faghih R; Liu H; Dwight W; Ireland L; Kang CH; Esbenshade TA; Bennani YL; Hancock AA
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3055-8. PubMed ID: 12372500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and structure-activity relationships of novel non-imidazole histamine H(3) receptor antagonists.
    Linney ID; Buck IM; Harper EA; Kalindjian SB; Pether MJ; Shankley NP; Watt GF; Wright PT
    J Med Chem; 2000 Jun; 43(12):2362-70. PubMed ID: 10882362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new class of histamine H(3)-receptor antagonists: synthesis and structure-activity relationships of 7,8,9,10-tetrahydro-6H-cyclohepta[b]quinolines.
    Turner SC; Esbenshade TA; Bennani YL; Hancock AA
    Bioorg Med Chem Lett; 2003 Jul; 13(13):2131-5. PubMed ID: 12798320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel nonimidazole histamine H3 receptor antagonists: 1-(4-(phenoxymethyl)benzyl)piperidines and related compounds.
    Mikó T; Ligneau X; Pertz HH; Ganellin CR; Arrang JM; Schwartz JC; Schunack W; Stark H
    J Med Chem; 2003 Apr; 46(8):1523-30. PubMed ID: 12672253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminoalkoxybiphenylnitriles as histamine-3 receptor ligands.
    Faghih R; Dwight W; Vasudevan A; Dinges J; Conner SE; Esbenshade TA; Bennani YL; Hancock AA
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3077-9. PubMed ID: 12372505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New histamine H(3)-receptor ligands of the proxifan series: imoproxifan and other selective antagonists with high oral in vivo potency.
    Sasse A; Sadek B; Ligneau X; Elz S; Pertz HH; Luger P; Ganellin CR; Arrang JM; Schwartz JC; Schunack W; Stark H
    J Med Chem; 2000 Aug; 43(17):3335-43. PubMed ID: 10966752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel histamine H(3)-receptor antagonists with carbonyl-substituted 4-(3-(phenoxy)propyl)-1H-imidazole structures like ciproxifan and related compounds.
    Stark H; Sadek B; Krause M; Hüls A; Ligneau X; Ganellin CR; Arrang JM; Schwartz JC; Schunack W
    J Med Chem; 2000 Oct; 43(21):3987-94. PubMed ID: 11052804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.
    Faghih R; Dwight W; Gentles R; Phelan K; Esbenshade TA; Ireland L; Miller TR; Kang CH; Fox GB; Gopalakrishnan SM; Hancock AA; Bennani YL
    Bioorg Med Chem Lett; 2002 Aug; 12(15):2031-4. PubMed ID: 12113835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in the proxifan class: heterocyclic congeners as novel potent and selective histamine H(3)-receptor antagonists.
    Grassmann S; Sadek B; Ligneau X; Elz S; Ganellin CR; Arrang JM; Schwartz JC; Stark H; Schunack W
    Eur J Pharm Sci; 2002 May; 15(4):367-78. PubMed ID: 11988398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of chiral N-alkylcarbamates as new leads for potent and selective H3-receptor antagonists: synthesis, capillary electrophoresis, and in vitro and oral in vivo activity.
    Sasse A; Kiec-Kononowicz K; Stark H; Motyl M; Reidemeister S; Ganellin CR; Ligneau X; Schwartz JC; Schunack W
    J Med Chem; 1999 Feb; 42(4):593-600. PubMed ID: 10052966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.
    Faghih R; Dwight W; Black L; Liu H; Gentles R; Phelan K; Esbenshade TA; Ireland L; Miller TR; Kang CH; Krueger KM; Fox GB; Hancock AA; Bennani YL
    Bioorg Med Chem Lett; 2002 Aug; 12(15):2035-7. PubMed ID: 12113836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CNS access of selected H3-antagonists: ex vivo binding study in rats.
    Ballabeni V; Impicciatore M; Bertoni S; Magnanini F; Zuliani V; Vacondio F; Barocelli E
    Inflamm Res; 2002 Apr; 51 Suppl 1():S55-6. PubMed ID: 12013409
    [No Abstract]   [Full Text] [Related]  

  • 13. 4-Alkynylphenyl imidazolylpropyl ethers as selective histamine H3-receptor antagonists with high oral central nervous system activity.
    Krause M; Ligneau X; Stark H; Garbarg M; Schwartz JC; Schunack W
    J Med Chem; 1998 Oct; 41(21):4171-6. PubMed ID: 9767653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diamine derivatives containing imidazolidinylidene propanedinitrile as a new class of histamine H3 receptor antagonists. Part I.
    Sasho S; Seishi T; Kawamura M; Hirose R; Toki S; Shimada JI
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2288-91. PubMed ID: 18353639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and pharmacological characterization of a series of new 1H-4-substituted-imidazoyl histamine H3 receptor ligands.
    Yates SL; Phillips JG; Gregory R; Pawlowski GP; Fadnis L; Khan MA; Ali SM; Tedford CE
    J Pharmacol Exp Ther; 1999 May; 289(2):1151-9. PubMed ID: 10215699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel histamine H3 receptor antagonists: synthesis and evaluation of formamidine and S-methylisothiourea derivatives.
    Goto T; Sakashita H; Murakami K; Sugiura M; Kondo T; Fukaya C
    Chem Pharm Bull (Tokyo); 1997 Feb; 45(2):305-11. PubMed ID: 9118445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histamine H(2) -like receptors in chick cerebral cortex: effects on cyclic AMP synthesis and characterization by [(3) H]tiotidine binding.
    Zawilska JB; Woldan-Tambor A; Nowak JZ
    J Neurochem; 2002 Jun; 81(5):935-46. PubMed ID: 12065605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Piperidine-containing histamine H3 receptor antagonists of the carbamate series: the alkyl derivatives.
    Lazewska D; Kieć-Kononowicz K; Elz S; Pertz HH; Stark H; Schunack W
    Pharmazie; 2005 Jun; 60(6):403-10. PubMed ID: 15997826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of trans-2-[1H-imidazol-4-yl] cyclopropane derivatives as new high-affinity histamine H3 receptor ligands.
    Tedford CE; Phillips JG; Gregory R; Pawlowski GP; Fadnis L; Khan MA; Ali SM; Handley MK; Yates SL
    J Pharmacol Exp Ther; 1999 May; 289(2):1160-8. PubMed ID: 10215700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and selective histamine H3 receptor antagonist with drug-like properties.
    Esbenshade TA; Fox GB; Krueger KM; Miller TR; Kang CH; Denny LI; Witte DG; Yao BB; Pan L; Wetter J; Marsh K; Bennani YL; Cowart MD; Sullivan JP; Hancock AA
    J Pharmacol Exp Ther; 2005 Apr; 313(1):165-75. PubMed ID: 15608078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.